| Ytd | -61.19% | |
| 1y | -93.56% |
| Open | 4.66 | Prev Close | 4.75 | Low | 4.60 | High | 4.76 | Mkt Cap | 274.74K |
| Vol | 6.45K | Avg Vol | 790.84K | EPS | -161.98 | P/E | -0.03 | Forward P/E | N/A |
| Beta | 2.79 | Short Ratio | 0.22 | Inst. Own | 1.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-24 | 50-d Avg | 6.49 | 200-d Avg | 12.25 | 1yr Est | 0.00 |
SPRC News
Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its subs
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciS
Toronto, Ontario – TheNewswire - July 15, 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company "
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s
Gainers VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-m
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte
Toronto, ON – July 2, 2026 - TheNewswire – NeuroThera Labs Inc. (the “ Company ” or “ NeuroThera ”)
Toronto, ON – TheNewswire - June 30, 2026 – NeuroThera Labs Inc. (the “ Company ” or “ NeuroThera ”)
TEL AVIV, Israel, June 04, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciS
Toronto, Ontario – June 3, 2026 – TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the “ Company ”
U.S. stocks rise, Dow Jones gains 200 points. NASDAQ up 0.73%, S&P 500 up 0.56%. Health care sha
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSp
Toronto, Ontario – May 27, 2026 - TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " o
May 20, 2026 – TheNewswire - Toronto, Ontario, Canada - Neurothera Labs Inc. (TSXV: NTLX) (“ Neuroth
April 30, 2026 – TheNewswire - Vancouver, British Columbia, Canada- Neurothera Labs Inc. (TSXV: NTLX
April 23, 2026 – TheNewswire - Vancouver, British Columbia, Canada - Neurothera Labs Inc. (TSXV: NTL
Amazon Inc (NASDAQ: AMZN) rose in pre-market trading after announcing a strategic collaboration with
Madrigal Pharmaceuticals (NASDAQ: MDGL - Get Free Report) and SciSparc (NASDAQ: SPRC - Get Free Repo
TEL AVIV, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “Sci
Vancouver, British Columbia – TheNewswire - March 16, 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the
TEL AVIV, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “Sci
Vancouver, British Columbia – March 11, 2026 – TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the
TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “Sci
Innovative non-hallucinogenic treatment combines MEAI with Palmitoylethanolamide to address obesity
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a
SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development